Ana
López Martín
Mario Negri Institute for Pharmacological Research
Milán, ItaliaPublicaciones en colaboración con investigadores/as de Mario Negri Institute for Pharmacological Research (1)
2017
-
Randomized Phase III Trial of Erlotinib versus Docetaxel in Patients with Advanced Squamous Cell Non–Small Cell Lung Cancer Failing First-Line Platinum-Based Doublet Chemotherapy Stratified by VeriStrat Good versus VeriStrat Poor. The European Thoracic Oncology Platform (ETOP) EMPHASIS-lung Trial
Journal of Thoracic Oncology, Vol. 12, Núm. 4, pp. 752-762